Azoles
Medchemexpress LLC HY-15602B 5mg Medchemexpress, Ledipasvir (D-tartrate) CAS:1502654-87-6 Purity:>98%
Medchemexpress, HY-15602B 5mg Ledipasvir (D-tartrate) CAS:1502654-87-6 Ledipasvir D-tartrate is an inhibitor of the hepatitis C virus NS5A, with EC50 values of 34 pM against GT1a and 4 pM against GT1b replicon. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
![eMolecules 5228-76-2 | 1H-Imidazol-2-yldiphenylmethanol | Oakwood Chemical | MFCD00958551 | 250.301 | C16H14N2O | 95.000 | OC(c1ncc[nH]1)(c1ccccc1)c1ccccc1 | 10mg | 537713411](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502150460.JPG-250.jpg)
eMolecules 5228-76-2 | 1H-Imidazol-2-yldiphenylmethanol | Oakwood Chemical | MFCD00958551 | 250.301 | C16H14N2O | 95.000 | OC(c1ncc[nH]1)(c1ccccc1)c1ccccc1 | 10mg | 537713411
1H-Imidazol-2-yldiphenylmethanol | Oakwood Chemical | 5228-76-2 | MFCD00958551 | 250.301 | C16H14N2O | 95.000 | OC(c1ncc[nH]1)(c1ccccc1)c1ccccc1 | 10mg | 537713411
Medchemexpress LLC HY-111503 5mg Medchemexpress, Y06137 CAS:2226534-49-0 Purity:>98%
Medchemexpress, HY-111503 5mg Y06137 CAS:2226534-49-0 Y06137 is a potent and selective BET inhibitor for treatment of castration-resistant prostate cancer (CRPC). Y06137 binds to the BRD4(1) bromodomain with a K d of 81 nM [1] . Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
![eMolecules 29043-48-9 | 2-Methyl-1H-benzoimidazol-5-ylamine | AA Blocks LLC | MFCD00462859 | 147.181 | C8H9N3 | 0.000 | Cc1nc2ccc(N)cc2[nH]1 | 1g | 433193774](https://assets.fishersci.com/TFS-Assets/CCG/product-images/NC3963089.jpg-250.jpg)
eMolecules 29043-48-9 | 2-Methyl-1H-benzoimidazol-5-ylamine | AA Blocks LLC | MFCD00462859 | 147.181 | C8H9N3 | 0.000 | Cc1nc2ccc(N)cc2[nH]1 | 1g | 433193774
2-Methyl-1H-benzoimidazol-5-ylamine | AA Blocks LLC | 29043-48-9 | MFCD00462859 | 147.181 | C8H9N3 | 0.000 | Cc1nc2ccc(N)cc2[nH]1 | 1g | 433193774
eMolecules 52708-36-8 | 4-(1H-Benzimidazol-1-yl)benzenamine | AA Blocks LLC | MFCD04971066 | 209.252 | C13H11N3 | 0.000 | Nc1ccc(cc1)-n1cnc2ccccc12 | 250mg | 932041499
4-(1H-Benzimidazol-1-yl)benzenamine | AA Blocks LLC | 52708-36-8 | MFCD04971066 | 209.252 | C13H11N3 | 0.000 | Nc1ccc(cc1)-n1cnc2ccccc12 | 250mg | 932041499
![eMolecules 6285-68-3 | 5-Methyl-1H-benzimidazol-2-amine | AA Blocks LLC | MFCD01658297 | 147.181 | C8H9N3 | 0.000 | Cc1ccc2[nH]c(N)nc2c1 | 1g | 410130349](https://assets.fishersci.com/TFS-Assets/CCG/product-images/NC3966432.jpg-250.jpg)
eMolecules 6285-68-3 | 5-Methyl-1H-benzimidazol-2-amine | AA Blocks LLC | MFCD01658297 | 147.181 | C8H9N3 | 0.000 | Cc1ccc2[nH]c(N)nc2c1 | 1g | 410130349
5-Methyl-1H-benzimidazol-2-amine | AA Blocks LLC | 6285-68-3 | MFCD01658297 | 147.181 | C8H9N3 | 0.000 | Cc1ccc2[nH]c(N)nc2c1 | 1g | 410130349
eMolecules 848035-21-2 | Medchem Express | Compound 48/80 (trihydrochloride) | 50mg | 746319632 | HY-130592 | 629.1 | C32H48Cl3N3O3
Medchem Express | Compound 48|80 (trihydrochloride) | 50mg | 746319632 | HY-130592 | 848035-21-2 | 629.100 | C32H48Cl3N3O3
eMolecules 118054-54-9 | (1-Methyl-1H-imidazol-2-yl)-acetic Acid | Toronto Research Chemicals | MFCD01231253 | 140.142 | C6H8N2O2Cn1ccnc1CC(O)=O | 100mg | 601598408
(1-Methyl-1H-imidazol-2-yl)-acetic Acid | Toronto Research Chemicals | 118054-54-9 | MFCD01231253 | 140.142 | C6H8N2O2Cn1ccnc1CC(O)=O | 100mg | 601598408
Medchemexpress LLC 5-amino-n-(2,6-difluorophenyl)-3-(4-sulfamoylanilino)-1,2,4-triazole-1-carbothioamide | 443798-47-8 | 425.44 g·mol⁻1 | C15H13F2N7O2S2 | 5 MG
This small-molecule research inhibitor targets cyclin-dependent kinases CDK1 and CDK2, with reported activity against CDC2-like kinases (CLK1 and CLK3). It is provided for biochemical and cellular research into cell-cycle regulation and kinase signaling. Handle with appropriate safety precautions; not for human or veterinary use.
- Potent CDK1 and CDK2 inhibitor with low-nanomolar activity.
- Also inhibits CDC2-like kinases (CLK1 and CLK3).
- Molecular formula C15H13F2N7O2S2, molecular weight 425.44 g·mol⁻1.
- Supplied as a solid for biochemical and cellular research applications.
- Storage: powder at -20°C (up to 3 years) or 4°C (up to 2 years); in solvent store at -80°C (up to 2 years).
- For research use only; not for human or veterinary use.
Strem, An Ascensus Company CAS# 141556-42-5. 500mg. 1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene, min. 98%. MFCD09265338
CAS# 141556-42-5. 500mg. 1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene, min. 98%. MFCD09265338. Molecular Weight: 304.43. Molecular Formula: C21H24N2. Color/form: white to off-white pwdr. Strem# 07-0600. http://www.strem.com/catalog/v/07-0600/
Aobchem 2-(3 5-Diisopropylphenyl)-4 4 5 5-tetramethyl-1 3 2-dioxaborolane | ≥95% | CAS 1025719-26-9 | C18H29BO2 | 500mg
2-(3 5-Diisopropylphenyl)-4 4 5 5-tetramethyl-1 3 2-dioxaborolane | ≥95% | CAS 1025719-26-9 | C18H29BO2 | 500mg
eMolecules 197079-08-6 | ETHYL 1-PHENYLIMIDAZOLE-4-CARBOXYLATE | AstaTech | MFCD11041365 | 216.240 | C12H12N2O2 | 97.000 | CCOC(=O)c1cn(cn1)-c1ccccc1 | 0.25g | 222803526
ETHYL 1-PHENYLIMIDAZOLE-4-CARBOXYLATE | AstaTech | 197079-08-6 | MFCD11041365 | 216.240 | C12H12N2O2 | 97.000 | CCOC(=O)c1cn(cn1)-c1ccccc1 | 0.25g | 222803526
Aobchem 2-(4-Bromo-3 5-difluorophenyl)-1 3-dioxolane | 97% | CAS 197785-24-3 | C9H7BrF2O2 | 250mg
2-(4-Bromo-3 5-difluorophenyl)-1 3-dioxolane | 97% | CAS 197785-24-3 | C9H7BrF2O2 | 250mg